47.40
0.45 (0.96%)
| Penutupan Terdahulu | 46.95 |
| Buka | 47.05 |
| Jumlah Dagangan | 1,668 |
| Purata Dagangan (3B) | 4,885 |
| Modal Pasaran | 511,441,280 |
| Harga / Jualan (P/S) | 3.05 |
| Harga / Buku (P/B) | 6.18 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 19 Aug 2025 |
| Margin Keuntungan | 37.21% |
| Margin Operasi (TTM) | 39.46% |
| EPS Cair (TTM) | -0.580 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 81.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -34.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 137.87% |
| Nisbah Semasa (MRQ) | 4.85 |
| Aliran Tunai Operasi (OCF TTM) | 74.36 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 48.68 M |
| Pulangan Atas Aset (ROA TTM) | 17.89% |
| Pulangan Atas Ekuiti (ROE TTM) | 218.58% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (GB) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | BASILEA PHARMACEUTICA AG BASILE | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 1.00 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| BASILEA PHARMACEUTICA AG BASILE | 511 M | - | - | 6.18 |
| PHARMA MAR SA PHARMA MAR ORD SH | 16 B | 1.08% | 14.69 | - |
| ARROWHEAD PHARMACEUTICALS INC A | 4 B | - | - | - |
| GENUS PLC ORD 10P | 2 B | 0.01% | 81.55 | 3.61 |
| AVACTA GROUP PLC ORD 10P | 353 M | - | - | 2.35 |
| PROTHENA CORPORATION PLC PROTHE | 330 M | - | 7.53 | - |
|
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.25% |
| % Dimiliki oleh Institusi | 31.15% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |